Showing results (991-1000 of 4,615) with videos related to

Sort By:
Pageof 462
Neuropharmacology|July 6, 2011
Mouse pharmacological models of cognitive disruption relevant to schizophreniaJared W Young, Susan B Powell, Mark A Geyer
Deutsche Medizinische Wochenschrift (1946)|June 5, 1987
[Alpha 2 -interferon therapy in metastasizing malignant melanoma]M Landthaler, C Geyer, U Papendick, et al.
Aging & Mental Health|April 29, 2022
The role of school education in time-dependent changes of cognitive abilities in cohorts from midlife to old ageSiegfried Geyer, Beatrice G Kuhlmann, Johannes Beller, et al.
ISPRS International Journal of Geo-Information|May 2, 2022
LionVu 2.0 Usability Assessment for Pennsylvania, United StatesNathaniel R Geyer, Fritz C Kessler, Eugene J Lengerich
The American Journal of Psychiatry|April 14, 1999
Symptom correlates of prepulse inhibition deficits in male schizophrenic patientsD L Braff, N R Swerdlow, M A Geyer
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 1, 1995
The behavior of APO-SUS rats in animal models with construct validity for schizophreniaB A Ellenbroek, M A Geyer, A R Cools
Journal of the South African Veterinary Association|September 1, 1996
Group B and C porcine rotaviruses identified for the first time in South AfricaA Geyer, T Sebata, I Peenze, et al.
Psychopharmacology|August 1, 1995
Presynaptic dopamine-glutamate interactions in the nucleus accumbens regulate sensorimotor gatingF J Wan, M A Geyer, N R Swerdlow
Pageof 462